Stockreport

AnaptysBio posts mid-stage trial setback for lead asset in ulcerative colitis [Seeking Alpha]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF Citing 12-week data, AnaptysBio ( ANAB ) said the study did More Trending News [Read more]